Back to
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
BSXShowing 8 of 29 quarters
Position history for
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP's holdings in BOSTON SCIENTIFIC CORP
Yes. Arrowstreet Capital holds 23,293,913 shares of BSX (Boston Scientific), worth $994.2M, as of its Q2 2026 13F filing. It increased the position by 9,402,245 shares (+67.7%) from Q1 2026. Arrowstreet Capital has held BSX since Q2 2021, across 21 quarterly 13F filings. BSX is 0.4% of Arrowstreet Capital's reported 13F portfolio.
Current Value
$994.2M
Current Shares
23.3M
Total Value Change
+$566.4M
Total Shares Change
+18.2M
Quarter-by-Quarter History
Other major holders of BSX: BlackRock, Inc., VANGUARD GROUP INC